| US 7,357,928 B2 | ||
| Method for the diagnosis and prognosis of malignant diseases | ||
| Paula J. Bates, Louisville, Ky. (US); Donald M. Miller, Louisville, Ky. (US); John O. Trent, Louisville, Ky. (US); and Xiaohua Xu, Louisville, Ky. (US) | ||
| Assigned to University of Louisville Research Foundation, Inc., Louisville, Ky. (US) | ||
| Filed on Oct. 09, 2003, as Appl. No. 10/683,480. | ||
| Application 10/683480 is a continuation in part of application No. 10/118854, filed on Apr. 08, 2002. | ||
| Prior Publication US 2005/0053607 A1, Mar. 10, 2005 | ||
| Int. Cl. A61K 39/395 (2006.01); A61K 51/00 (2006.01); A01N 61/00 (2006.01) | ||
| U.S. Cl. 424—130.1 [424/1.11; 514/1] | 21 Claims |
| 1. A method of treating cancer in a mammal comprising administering to said mammal a therapeutically effective amount of an
anti-nucleolin agent and a pharmaceutically acceptable carrier;
wherein the anti-nucleolin agent comprises a nucleolin monoclonal antibody.
|